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Abstract
Introduction: Chronic necrotizing pulmonary aspergillosis is an uncommon subacute form of Aspergillus infection.
It typically occurs in immunocompromised individuals and in those with underlying lung disease. This interesting
case highlights the occurrence of this entity of aspergillosis in an immunocompetent middle-aged woman with
atypical radiological findings. To the best of our knowledge this is the first case report of chronic necrotizing
pulmonary aspergillosis presenting with pleural effusion.
Case presentation: Our patient was a 64-year-old Malay woman with a background history of epilepsy but no
other comorbidities. She was a lifelong non-smoker. She presented to our facility with a six-month history of
productive cough and three episodes of hemoptysis. An initial chest radiograph showed bilateral pleural effusion
with bibasal consolidation. Bronchoscopy revealed a white-coated endobronchial tree and bronchoalveolar lavage
culture grew Aspergillus niger. A diagnosis of chronic necrotizing pulmonary aspergillosis was made based on the
clinical presentation and microbiological results. She responded well to treatment with oral itraconazole.
Conclusions: The radiological findings in chronic necrotizing pulmonary aspergillosis can be very diverse. This case
illustrates that this condition can be a rare cause of bilateral pleural effusion.
Introduction
Chronic necrotizing pulmonary aspergillosis (CNPA)
corresponds to an indolent process of lung destruction
caused by the Aspergillus fungus, generally A. fumigates
[1]. This entity is different from an aspergilloma, as a
pre-existing cavity is not needed, although a cavity may
develop in the lung as a secondary phenomenon. In
contrast to invasive aspergillosis, CNPA occurs over a
period of months to years and there is no vascular inva-
sion or dissemination to other organs. The main risk
factors are: chronic obstructive pulmonary disease,
sequelae of tuberculosis, pulmonary resection, radiation-
induced pulmonary fibrosis, pneumoconiosis, cystic
fibrosis, pulmonary infarction and sarcoidosis. Other
immunosuppression conditions, such as diabetes melli-
tus, malnutrition, alcoholism, connective tissue diseases
and prolonged corticosteroid therapy, are also situations
of increased risk [1-3].
Results from chest X-rays may reveal unilateral or
bilateral infiltrates with or without cavitation and pleural
thickness, especially in the upper lobes and in the upper
segments of the lower lobes. In 50% of the cases an
aspergilloma occurs simultaneously [1-4]. The definite
diagnosis is made through the histological demonstra-
tion of tissue invasion by the fungus and the growth of
Aspergillus species in a culture [2,5].
Other helpful tests include serum IgG antibodies to
Aspergillus and immediate skin reactivity for Aspergillus
antigens. Due to the difficulty in confirming the diagno-
sis, the following diagnosis criteria were established and
together are highly indicative of CNPA: characteristic
clinical and radiological findings, elevation of inflamma-
tory markers (C-reactive protein (CRP), erythrocyte
sedimentation rate (ESR)) and either serological test
results positive for Aspergillus or the isolation of Asper-
gillus from respiratory samples. Active tuberculosis,
non-tuberculosis mycobacteriosis, cavitary histoplasmo-
sis and coccidioidomycosis should be excluded [2,5].
Galactomannan and polymerase chain reaction (PCR)
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tests from bronchoalveolar lavage, as well as cutaneous
sensitivity tests for Aspergillus, do not have a confirmed
use in diagnosis [2,5].
Therapy with voriconazole or itraconazole has
emerged as the first-line treatment and is safer than
amphotericin B [6]. The long-term prognosis for
patients with CNPA is not well documented. The ideal
treatment duration has not yet been defined and
depends on the extension of the disease, the patient’s
response to treatment, the base disease and the patient’s
immunological condition. In some cases, lifelong therapy
may be required [7].
Case presentation
Our patient, a 64-year-old woman who was a non-smo-
ker with a background history of epilepsy, presented to
our respiratory clinic in May 2008 with a six-month his-
tory of productive cough with whitish sputum associated
with three episodes of hemoptysis. She had no constitu-
tional symptoms. At a primary care clinic a diagnosis of
tuberculosis (TB) was considered, but the results of a
Mantoux test were negative and findings from the three
sputum acid-fast bacilli samples and cultures for TB
were also negative. Her symptoms were persistent
despite a few courses with oral antibiotics such as oral
amoxicillin, azithromycin and moxifloxacin. On exami-
nation, our patient was emaciated (body mass index of
19.3 kg/m2), hemodynamically stable, apyretic, eupneic
and with peripheral oxygen saturation (SpO2) of 98%
(FiO2 21%). She did not have clubbed fingers, palpable
cervical lymph nodes or oral thrush.
A bacillus Calmette-Guérin (BCG) scar was present. Her
jugular venous pressure was not elevated, and her apex
beat was not displaced. An examination of her respiratory
system revealed reduced breath sounds at the bases. Based
on our patient’s history and the physical examination, the
differential diagnoses were bronchogenic carcinoma, pul-
monary tuberculosis and bronchiectasis.
The results of initial investigations showed a normocy-
tic normochromic anemia (hemoglobin level of 10.3 g/
dL) with normal white cell and platelet counts. Her
inflammatory markers were raised: her CRP was 3.24
mmol/L and ESR was 66 mm/hour. Other blood investi-
gations were normal. An initial chest radiograph showed
bilateral pleural effusion with bibasal consolidation (Fig-
ure 1). A thoracocentesis procedure was not performed
as the pleural effusion looked minimal. Subsequently,
bronchoscopy was performed, showing an edematous
and white coated bronchial tree mucosa; the right lower
lobe mucosa had an infiltrate appearance. The
Figure 1 Pre-treatment and post-treatment chest radiographs. After two months of antifungal therapy, there was complete resolution of
the bilateral pleural effusion with significant improvement in the bibasal consolidation.
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mycological bronchoalveolar lavage culture tested posi-
tive for Aspergillus niger. The mycobacterial cultures
tested negative. Unfortunately, a transbronchial biopsy
was not performed in the same setting.
Fulfilling the proposed diagnostic criteria by Soubani
et al. [2], a diagnosis of chronic necrotizing pulmonary
aspergillosis was made based on the subacute presenta-
tion of six months’ duration and microbiological culture
that grew A. niger. Our patient was discharged with itra-
conazole 200 mg (syrup) to be taken once daily for an
estimated duration of six months. The syrup form was
chosen instead of the capsule form for better absorption.
After two months of treatment, clinical and radiological
improvements were noted on follow-up tests. The itra-
conazole syrup was continued, aiming for a minimum
treatment duration of six months.
Discussion
The radiological findings of bilateral pleural effusion with
lower lung field involvement were not typical of CNPA.
Additionally, A. niger is a rare causative organism of
CNPA, unlike Aspergillus fumigates. To the best of our
knowledge, this is the first case report of pleural effusion
in CNPA. The diagnosis was made six months from the
time of onset of symptoms. The atypical presentation
delayed the diagnosis. In a case series of 43 patients with
CNPA, the upper lobes were frequently involved. The
radiological findings in CNPA were very diverse. The
reported radiological characteristics were parenchymal
consolidation, mycetoma, cavitation, bronchopulmonary
fistula, bronchiectasis and emphysema. None of the
patients had pleural effusion [2]. However, there were
case reports of other forms of aspergillosis, that is, aller-
gic bronchopulmonary aspergillosis and invasive aspergil-
losis presenting with pleural effusion [4,5].
We believe that the parapneumonic effusion was sec-
ondary to pleural inflammation caused by fungal infiltra-
tion. The identification of Aspergillus in the pleural
biopsy would have been confirmatory. This investigation
was not performed given that the mycological bronch-
oalveolar lavage culture tested positive for A. niger.
Chronic necrotizing Aspergillus pneumonia has a
reported mortality rate of 10% to 40%, but the rates
could be higher as this entity is under-diagnosed [6].
The wide spectrum and non-specific radiological find-
ings make it more challenging to diagnose this
condition.
Our patient was fortunate to have responded well to
oral itraconazole. The rapid response was most probably
due to her immunocompetent state. In one study, only
38% of patients showed either clinical or radiological
improvement with oral itraconazole after more than
three months of treatment [2].
Conclusions
Parapneumonic effusion is a recognized complication of
chest infections caused by a wide variety of organisms.
This case clearly demonstrates that clinicians should be
vigilant and consider CNPA as a differential diagnosis
even in healthy patients with unresolving pneumonia
manifesting with bilateral pleural effusion.
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